Skip to main content
 

Alerts and Recalls

Top
  • Texas Board of Nursing (BON) to Implement Disaster Licensing Procedure

    Tuesday, August 29, 2017
    The Texas BON is implementing a disaster licensing procedure to respond to this declared disaster.

    Read More
  • ESRD Network of Texas Disaster Updates

    Sunday, August 27, 2017
    ESRD Network of Texas maintains a comprehensive list of resources and materials on their website. The Network also actively participates in the Texas ESRD Emergency Coalition (TEEC).

    Read More
  • Harvey: A Life Threatening Hurricane

    Friday, August 25, 2017
    Hurricane Harvey is a life-threatening and rapidly intensifying storm that is expected to make landfall on the Texas Gulf Coast with devastating rainfall flooding, dangerous storm surge flooding, and destructive winds.

    Read More
  • Bella Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to Lack of Sterility Assurance

    Monday, August 21, 2017
    Bella Pharmaceuticals is voluntarily recalling all lots of unexpired sterile drug products due to lack of sterility assurance. The recalled products were distributed to health care facilities nationwide.

    Read More
  • Lorazepam Oral Concentrate, USP 2mg/mL by Amneal Pharmaceuticals: Recall - Misprinted Dosing Droppers

    Wednesday, August 16, 2017
    Amneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in the dropper markings. The Lorazepam Oral Concentrate, USP 2mg/mL, product is packaged with a dosing dropper, supplied to Amneal by a third party.

    Read More
  • Pravastatin Sodium Tablets by International Laboratories: Recall - Mislabeling

    Friday, August 11, 2017
    International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg...

    Read More
  • Liquid Drug Products Manufactured by PharmaTech and Distributed by Rugby Laboratories and Possibly Other Companies: FDA Advisory - Not to Use

    Thursday, August 10, 2017
    FDA is advising health care professionals and patients not to use any liquid product manufactured by PharmaTech LLC, Davie, Florida, due to Burkholderia cepacia contamination and the potential for severe patient infection. Rugby Laboratories, Livonia, Michigan, announced a voluntary recall on...

    Read More
  • Increase in Reported cases of Cyclospora cayetanensis Infection, United States, Summer 2017

    Monday, August 7, 2017
    The Centers for Disease Control and Prevention (CDC), State and Local Health Departments, and the Food and Drug Administration (FDA) are investigating an increase in reported cases of cyclosporiasis. The purpose of this HAN Advisory is to notify public health departments and healthcare facilities...

    Read More
  • Diocto Liquid and Diocto Syrup by Rugby Laboratories: Recall - Possible Product Contamination

    Thursday, August 3, 2017
    Rugby Laboratories is voluntarily recalling all lots of Diocto Liquid and Diocto Syrup, (docusate sodium solutions) manufactured by PharmaTech, LLC due to a risk of product contamination with Burkholderia cepacia. FDA informed Rugby that it received several adverse event reports of B. cepacia...

    Read More
  • 0.9% Sodium Chloride Injection by ICU Medical: Recall

    Monday, July 31, 2017
    ICU Medical, Inc. is voluntarily recalling one lot of 0.9% Sodium Chloride Injection, USP 1000 mL to the hospital/user level due to a confirmed customer complaint of particulate matter identified as stainless steel within a single flexible container. Injection of particulate matter could...

    Read More